Bain Capital is reportedly in talks with Dr Reddy’s Laboratories to consider a joint bid for buying out promoters’ stake in Cipla. Fintech firm BharatPe has approached its existing investors to raise $100 million in an equity funding round while Nazara Technologies is looking to raise up to $12 million.
Bain Capital in talks with Dr Reddy’s for Cipla joint bid
Bain Capital is in talks with Dr Reddy’s Laboratories to consider a joint bid for buying out promoters of Cipla, according to The Economic Times.
Pharmaceutical major Cipla was exploring a stake sale to private equity majors including Blackstone and Baring Asia in July this year. The promoters currently own a 33.47 % stake in the company.
The pharma firm has also been looking for a strategic investor to renew its future strategy to enhance capital allocation, and operational efficiency and to improve return metrics.
Nazara Technologies to raise up to $12m
Nazara Technologies, a diversified gaming and sports media platform, has received approval from its board to raise up to $12 million through preferential allotment of equity shares.
The company is proposing to issue 14,00,560 equity shares of face value of Rs 4 each to Kamath Associates and NKSquared. The fresh capital will be used to make strategic acquisitions and investments in various companies.
Nazara is currently India’s only listed gaming and e-sports company with majority ownership of a number of leading gaming and e-sports brands with a presence in India, the US, and other global markets.
BharatPe eyeing to raise $100m in equity funding
Fintech firm BharatPe has approached its existing investors to raise $100 million in an equity funding round, according to The Economic Times.
The company acquired a majority stake in Trillion Loans for an undisclosed amount in May this year. Founded in 2018, BharatPe competes with Paytm and Google Pay in India.
